🔗 Permalink

Inventor profile of:

Mark Paris

City:

Mendon, New York

Country:

United States

Published Applications:

Last publication date:

2024-09-19

Top Assignees for applications by Mark Paris

The entities that hold a legal rights for patent applications filed by inventor Paris Mark:

Vaccinex, Inc. 12 Rochester, NY United States

Recent patent applications by Paris Mark

Mark Paris from Mendon, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-09-19

US20240309091A1

Chemistry; metallurgy

HUMAN ANTI-SEMAPHORIN 4D ANTIBODY

#2 | 2022-11-10

US20220356249A1

Chemistry; metallurgy

Human anti-semaphorin 4D antibody

#3 | 2021-03-25

US20210087263A1

Chemistry; metallurgy

Anti-CXCL13 antibodies and methods of using the same

#4 | 2021-02-04

US20210032329A1

Chemistry; metallurgy

Human anti-semaphorin 4D antibody

#5 | 2020-07-09

US20200216562A1

Chemistry; metallurgy

Integral membrane protein display on poxvirus extracellular enveloped virions

#6 | 2019-09-12

US20190276556A1

Chemistry; metallurgy

Integral membrane protein display on poxvirus extracellular enveloped virions

#7 | 2019-04-18

US20190112388A1

Chemistry; metallurgy

Integral membrane protein display on poxvirus extracellular enveloped virions

#8 | 2018-08-30

US20180244764A1

Chemistry; metallurgy

Polynucleotides encoding anti-CXCL13 antibodies

#9 | 2017-10-26

US20170306318A1

Chemistry; metallurgy

Method for selecting polynucleotides encoding antigen-specific immunoglobulin subunit

#10 | 2016-01-07

US20160002325A1

Chemistry; metallurgy

ANTI-CXCL13 ANTIBODIES AND ASSOCIATED EPITOPE SEQUENCES

#11 | 2015-02-19

US20150050287A9

Chemistry; metallurgy

Anti-CXCL13 antibodies and methods of using the same

#12 | 2014-05-29

US20140147447A1

Chemistry; metallurgy

ANTI-CXCL13 ANTIBODIES AND METHODS OF USING THE SAME

InventorID:

778154 ⎘